In this study should be investigated, if the vaccination against App during a viremia induced by PRRSV-vaccine (MLV), affects the serological response against App.
The study, in which wIVD GmbH was also involved can be found here
Status 01/2026
against Actinobacillus pleuropneumoniae (APP) and against the Porcine Reproductive and Respiratory syndrome Virus (PRRSV)
In this study should be investigated, if the vaccination against App during a viremia induced by PRRSV-vaccine (MLV), affects the serological response against App.
The study, in which wIVD GmbH was also involved can be found here
Status 01/2026
CONTACT
IVD GmbH
Albert-Einstein-Straße 5
30926 Seelze-Letter
Tel.: (0511) 220029-0
Fax: (0511) 220029-99
E-Mail: service@ivd-gmbh.de
Imprint | Privacy Policy |
General Terms & Conditions | Accessibility
2025 © IVD GmbH Hannover
QUICKLINKS
EXTERNE LINKS
ilac.org
dakks.de
dvg.net
stifterverband.org
q-s.de
